Related Experiment Video
Updated: May 17, 2026
Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
A Diagnostic Algorithm for Mitochondrial Disorders in Estonian Children
K Joost1, R J Rodenburg, A Piirsoo
1Department of Genetics, United Laboratories, Tartu, Estonia ; The Centre of Excellence for Translational Medicine, University of Tartu, Tartu, Estonia.
Insights
This study developed a diagnostic algorithm for childhood mitochondrial disorders in Estonia, identifying 5 cases and a live-birth prevalence of 1/20,764. Findings align with international data, aiding clinical practice and understanding of these energy production diseases.
Area of Science:
- Pediatric Neurology
- Biochemistry
- Genetics
Background:
- Mitochondrial disorders are complex genetic conditions impacting cellular energy production.
- Existing diagnostic criteria (Wolfson, Nijmegen, modified Walker) present challenges in pediatric cases.
- A need exists for a practical diagnostic algorithm for Estonian pediatric neurology and neonatology.
Purpose of the Study:
- To develop and implement a diagnostic algorithm for identifying mitochondrial disorders in Estonian pediatric patients.
- To evaluate the live-birth prevalence of childhood mitochondrial disorders within the study cohort.
- To compare epidemiological data with international findings.
Main Methods:
- Retrospective analysis of 22 children referred for muscle biopsy (2003-2009) based on preliminary investigations.
- Enzymatic and molecular analyses to confirm diagnoses.
- Calculation of live-birth prevalence based on confirmed cases.
Main Results:
- Mitochondrial disease was confirmed in 5 out of 22 children.
- Confirmed diagnoses included SCO2 gene defect, pyruvate dehydrogenase complex deficiency (2 cases), and combined complex I and IV deficiency (2 cases).
- The observed live-birth prevalence was 1/20,764, consistent with data from Sweden and Australia, but lower than Finland.
Conclusions:
- The developed diagnostic algorithm is applicable to clinical practice in Estonia for identifying pediatric mitochondrial disorders.
- The study provides crucial epidemiological data on mitochondrial disease prevalence in childhood.
- Findings support the need for continued research and standardized diagnostic approaches for these debilitating conditions.
Abstract:
Mitochondrial disorders are a heterogeneous group of disorders affecting energy production of the body. Different consensus diagnostic criteria for mitochondrial disorders in childhood are available - Wolfson, Nijmegen and modified Walker criteria. Due to the extreme complexity of mitochondrial disorders in children, we decided to develop a diagnostic algorithm, applicable in clinical practice in Estonia, in order to identify patients with mitochondrial disorders among pediatric neonatology and neurology patients. Additionally, it was aimed to evaluate the live-birth prevalence of mitochondrial disorders in childhood. During the study period (2003-2009), a total of 22 children were referred to a muscle biopsy in suspicion of mitochondrial disorder based on the preliminary biochemical, metabolic and instrumental investigations. Enzymatic and/or molecular analysis confirmed mitochondrial disease in 5 of them - an SCO2 gene (synthesis of cytochrome c oxidase, subunit 2) defect, 2 cases of pyruvate dehydrogenase complex deficiency and 2 cases of combined complex I and IV deficiency. The live-birth prevalence for mitochondrial defects observed in our cohort was 1/20,764 live births. Our epidemiological data correlate well with previously published epidemiology data on mitochondrial diseases in childhood from Sweden and Australia, but are lower than in Finland.
